194 related articles for article (PubMed ID: 16491628)
21. Drug resistance in diffuse large B-cell lymphoma.
Wilson WH
Semin Hematol; 2006 Oct; 43(4):230-9. PubMed ID: 17027657
[TBL] [Abstract][Full Text] [Related]
22. Sixth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin lymphoma.
Weingart O; Rehan FA; Schulz H; Naumann F; Knauel I; Bohlius CB; Engert A
J Natl Cancer Inst; 2007 Sep; 99(17):E1. PubMed ID: 17728205
[No Abstract] [Full Text] [Related]
23. [Treatment of diffuse large B-cell lymphoma].
Gleissner B; Zwick C; Pfreundschuh M
Dtsch Med Wochenschr; 2008 Sep; 133(36):1785-94; quiz 1795-6. PubMed ID: 18767006
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
[TBL] [Abstract][Full Text] [Related]
25. [Malignant lymphoma].
Mori T
Gan To Kagaku Ryoho; 2007 Feb; 34(2):162-6. PubMed ID: 17301521
[TBL] [Abstract][Full Text] [Related]
26. Remission of a refractory, anaplastic large-cell lymphoma after treatment with daclizumab.
Lindén O
N Engl J Med; 2004 Sep; 351(14):1466-7. PubMed ID: 15459315
[No Abstract] [Full Text] [Related]
27. Who should receive myeloablative therapy for diffuse large B-cell lymphoma?
Wannesson L; Zucca E
Nat Clin Pract Oncol; 2008 Aug; 5(8):442-3. PubMed ID: 18607392
[No Abstract] [Full Text] [Related]
28. Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion.
Piccaluga PP; Vigna E; Placci A; Agostinelli C; Laterza C; Papayannidis C; Leone O; Martinelli G; Zinzani PL; Baccarani M; Pileri SA
Br J Haematol; 2006 Aug; 134(4):356. PubMed ID: 16882130
[No Abstract] [Full Text] [Related]
29. Array-based comparative genomic hybridisation analysis reveals recurrent chromosomal alterations in primary diffuse large B cell lymphoma of bone.
Heyning FH; Jansen PM; Hogendoorn PC; Szuhai K
J Clin Pathol; 2010 Dec; 63(12):1095-100. PubMed ID: 20962053
[TBL] [Abstract][Full Text] [Related]
30. Clinical Trails Broadcast: CALGB 50303 and CTSU 50303.
Clin Adv Hematol Oncol; 2006 Nov; 4(11):848-50. PubMed ID: 17143255
[No Abstract] [Full Text] [Related]
31. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
Collins-Burow B; Santos ES
Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
[TBL] [Abstract][Full Text] [Related]
32. Rituximab for early-stage diffuse large-B-cell lymphoma.
Friedberg JW
Lancet Oncol; 2006 May; 7(5):357-9. PubMed ID: 16648037
[No Abstract] [Full Text] [Related]
33. Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
Grange F; Maubec E; Bagot M; Beylot-Barry M; Joly P; Dalle S; Delaporte E; Dereure O; Bachelez H; Vergier B; Petrella T; D'Incan M
Arch Dermatol; 2009 Mar; 145(3):329-30. PubMed ID: 19289772
[No Abstract] [Full Text] [Related]
34. A diagnosis dilemma of back pain in non-Hodgkin lymphoma.
Cheung W; Maksymiuk A
Pediatr Blood Cancer; 2005 Jan; 44(1):100-1. PubMed ID: 15459962
[No Abstract] [Full Text] [Related]
35. [Gene expression profiling of de novo CD5-positive diffuse large B-cell lymphoma].
Kobayashi T; Kim S; Zhang W; Yamaguchi M; Ueno S; Morikawa J; Shiku H
Rinsho Ketsueki; 2003 Mar; 44(3):144-8. PubMed ID: 12722340
[No Abstract] [Full Text] [Related]
36. New concepts in treatment approaches and prognostic factors in aggressive NHL.
Shipp M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):107-9. PubMed ID: 16728917
[No Abstract] [Full Text] [Related]
37. Rituximab and chemotherapy in diffuse large B-cell lymphoma.
Sonet A; Bosly A
Expert Rev Anticancer Ther; 2009 Jun; 9(6):719-26. PubMed ID: 19496708
[TBL] [Abstract][Full Text] [Related]
38. Molecular characteristics of diffuse large-B-cell lymphoma.
Magrath I
N Engl J Med; 2002 Jun; 346(25):1998-9. PubMed ID: 12075062
[No Abstract] [Full Text] [Related]
39. Challenging problems in advanced malignancy: Case 1. Chylopericardium during the treatment of non-Hodgkin's lymphoma.
Lee YH; Im SA; Nam SH; Lee SN; Kim Y; Seong CM; Han WS; Lee SW; Park SH; Lee SN
J Clin Oncol; 2003 Aug; 21(16):3168-70. PubMed ID: 12915608
[No Abstract] [Full Text] [Related]
40. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas.
Jardin F; Ruminy P; Kerckaert JP; Parmentier F; Picquenot JM; Quief S; Villenet C; Buchonnet G; Tosi M; Frebourg T; Bastard C; Tilly H
Haematologica; 2008 Apr; 93(4):543-50. PubMed ID: 18287131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
